Ilyang Pharm Valuation
| 007570 Stock | 11,130 70.00 0.63% |
At this time, the firm appears to be overvalued. Ilyang Pharm retains a regular Real Value of USD9126.6 per share. The prevalent price of the firm is USD11130.0. Our model calculates the value of Ilyang Pharm from evaluating the firm fundamentals such as Current Valuation of 396.95 B, return on equity of 0.12, and Return On Asset of 0.0597 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ilyang Pharm's price fluctuation is very steady at this time. Calculation of the real value of Ilyang Pharm is based on 3 months time horizon. Increasing Ilyang Pharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ilyang Pharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ilyang Stock. However, Ilyang Pharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11130.0 | Real 9126.6 | Hype 11130.0 |
The real value of Ilyang Stock, also known as its intrinsic value, is the underlying worth of Ilyang Pharm Company, which is reflected in its stock price. It is based on Ilyang Pharm's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ilyang Pharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ilyang Pharm helps investors to forecast how Ilyang stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ilyang Pharm more accurately as focusing exclusively on Ilyang Pharm's fundamentals will not take into account other important factors: Ilyang Pharm Total Value Analysis
Ilyang Pharm is presently forecasted to have takeover price of 396.95 B with market capitalization of 345.28 B, debt of 5.02 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ilyang Pharm fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
396.95 B | 345.28 B | 5.02 B |
Ilyang Pharm Investor Information
About 27.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.56. In the past many companies with similar price-to-book ratios have beat the market. Ilyang Pharm last dividend was issued on the 28th of December 2022. The entity had 2:1 split on the 28th of June 2006. Based on the analysis of Ilyang Pharm's profitability, liquidity, and operating efficiency, Ilyang Pharm is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Ilyang Pharm Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ilyang Pharm has an asset utilization ratio of 75.13 percent. This suggests that the Company is making USD0.75 for each dollar of assets. An increasing asset utilization means that Ilyang Pharm is more efficient with each dollar of assets it utilizes for everyday operations.Ilyang Pharm Ownership Allocation
Ilyang Pharm has a total of 18.09 Million outstanding shares. Ilyang Pharm secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Ilyang Pharm Profitability Analysis
The company reported the revenue of 371.35 B. Net Income was 14.38 B with profit before overhead, payroll, taxes, and interest of 204.29 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ilyang Pharm's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ilyang Pharm and how it compares across the competition.
About Ilyang Pharm Valuation
The stock valuation mechanism determines Ilyang Pharm's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ilyang Pharm. We calculate exposure to Ilyang Pharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ilyang Pharm's related companies.8 Steps to conduct Ilyang Pharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ilyang Pharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ilyang Pharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ilyang Pharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ilyang Pharm's revenue streams: Identify Ilyang Pharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ilyang Pharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ilyang Pharm's growth potential: Evaluate Ilyang Pharm's management, business model, and growth potential.
- Determine Ilyang Pharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ilyang Pharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Ilyang Stock analysis
When running Ilyang Pharm's price analysis, check to measure Ilyang Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilyang Pharm is operating at the current time. Most of Ilyang Pharm's value examination focuses on studying past and present price action to predict the probability of Ilyang Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilyang Pharm's price. Additionally, you may evaluate how the addition of Ilyang Pharm to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |